Benzathine Benzylpenicillin — Injection Risks, Side Effects, and Consequences of Use
EFFECTIVE | TOXIC
Names Under Which the Drug Is Available
International nonproprietary name: benzathine benzylpenicillin; Latin variants: Benzathine benzylpenicillin, Benzylpenicillin benzathine; American name: Penicillin G benzathine; the spellings benzathine penicillin G and benzathine penicillin are also used. The dosage form is a powder or a ready-to-use long-acting suspension for deep intramuscular administration. The main trade names used in different countries are Bicillin-1, Bicillin L-A, Extencilline, Retarpen, Lentocilin, Penadur, and Tardocillin. Benzathine benzylpenicillin as a single-agent product must be distinguished from combination formulations: Bicillin C-R contains benzathine benzylpenicillin and procaine benzylpenicillin, while Bicillin C-R 900/300 contains the same components in a different ratio. These products are not interchangeable for all indications. In particular, combination Bicillin C-R must not be regarded as equivalent to Bicillin L-A in the treatment of syphilis.
Why the Drug Is Considered Harmless and Where the Real Risk Begins
A single injection of benzathine benzylpenicillin can cause not only pain in the buttock, but also anaphylactic shock, severe tissue injury, a vascular catastrophe at the injection site, or respiratory and circulatory arrest if the suspension enters a blood vessel. The long-acting formulation creates a depot from which the antibiotic is released for weeks, so the drug cannot be removed or rapidly discontinued after injection. Accidental intravenous administration is officially associated with cardiorespiratory arrest and death. A false sense of safety develops because the drug has been used for decades, is administered once or infrequently, and is usually tolerated without an immediate catastrophic reaction. However, previous uneventful injections do not rule out sensitisation and anaphylaxis with the next dose.
Side Effects After the First Injection and in the Short Term
The most common reactions are marked pain, induration, inflammation and swelling at the injection site, headache, nausea, diarrhoea, fever, skin rash, itching, and urticaria. Clinically significant complications include a serum sickness-like reaction, drug fever, angioedema, bronchospasm, hypotension, antibiotic-associated diarrhoea, and colitis caused by Clostridioides difficile. An allergic reaction may occur within minutes after administration, although some immune-mediated manifestations develop hours or days later. Anaphylaxis presents with sudden shortness of breath, wheezing, a drop in blood pressure, generalised urticaria, swelling of the face or larynx, impaired consciousness, and circulatory collapse.
During treatment of early syphilis, a Jarisch–Herxheimer reaction may occur within the first 24 hours, with fever, chills, headache, myalgia, tachycardia, and a temporary worsening of infection symptoms. This is an inflammatory response to the destruction of treponemes rather than an allergy to penicillin. However, it can worsen the patient’s condition and is particularly important during pregnancy and in patients with neurological or cardiovascular involvement. In studies of early syphilis, the frequency of this reaction varied considerably depending on the population and diagnostic criteria.
A rare but devastating complication is Nicolau syndrome, an ischaemic injury of the skin, subcutaneous tissue, and muscles following intramuscular injection. The first sign is usually disproportionately severe, burning pain occurring during or shortly after the injection, followed by pallor, retiform bluish discolouration, swelling, blistering, and necrosis. Limb paralysis, compartment syndrome, gangrene, acute kidney failure, amputation, and death have been reported.
Consequences of Repeated and Long-Term Use
Benzathine benzylpenicillin does not cause drug dependence, tolerance, or a classic withdrawal syndrome. Its main long-term risk is not cumulative liver or kidney toxicity, but repeated antigen exposure, disruption of the microbiota, and selection of resistant microorganisms. Delayed allergic reactions that were absent after previous injections may develop after repeated courses. Candidiasis and superinfection with non-susceptible bacteria may occur, while antibiotic-associated colitis may begin not only during treatment but also after it has ended.
For long-term prevention of rheumatic fever, injections are administered regularly for many months or years. Under these conditions, the cumulative probability of local complications, errors in injection technique, and immune reactions increases, although the drug does not typically cause dose-dependent organ toxicity. The absence of a reaction after several injections must not be regarded as a guarantee that the next injection will be safe. Unjustified repeated use of the antibiotic can also mask an incorrect diagnosis and create the appearance of treatment when the illness is actually viral, inflammatory, or otherwise non-bacterial in origin.
Contraindications and High-Risk Groups
An absolute contraindication is confirmed severe hypersensitivity to penicillins. In patients who have experienced anaphylaxis, angioedema, or a severe skin reaction to any penicillin, repeat administration without specialist assessment may be fatal. Cross-reactions are possible in patients allergic to other β-lactam antibiotics, including cephalosporins.
The drug must not be administered intravenously, intra-arterially, subcutaneously, or near a major nerve or vascular bundle. Intravascular entry of the thick suspension may cause embolism, ischaemia, severe neurovascular injury, cardiorespiratory arrest, and death. In infants and young children, the risk of vascular injury and incorrect selection of the injection site is particularly significant because of their smaller anatomical dimensions.
In patients with kidney failure, exposure to the released benzylpenicillin may be prolonged, increasing the risk of neurotoxic reactions, especially when excessive doses are prescribed or the drug is combined with other penicillins. Patients with bronchial asthma, atopic disorders, and multiple drug allergies have a higher risk of hypersensitivity reactions, although the absence of an allergy history does not rule out anaphylaxis. If neurosyphilis or ocular syphilis is suspected, benzathine benzylpenicillin does not provide the required concentrations in the central nervous system and must not replace the appropriate intravenous treatment.
Dangerous Drug Combinations
No contraindicated everyday combinations with food, caffeine, or nicotine have been established for benzathine benzylpenicillin because the drug is administered intramuscularly and absorbed from a depot. Alcohol does not cause a classic disulfiram-like reaction with it, but drinking alcohol during treatment of an infection may worsen weakness, dehydration, and gastrointestinal disturbances. There is no basis for considering this combination beneficial or completely harmless.
Combining the drug with bacteriostatic antibiotics without clear clinical justification is highly undesirable because, in theory, they may weaken the effect of penicillin on actively dividing bacteria. Probenecid reduces renal tubular secretion of penicillin and increases or prolongs its concentration. Such a combination is acceptable only as a deliberate medical decision. Penicillins may reduce the renal elimination of methotrexate and increase the risk of myelotoxicity, mucositis, and other manifestations of toxicity, so laboratory monitoring is required.
The antibiotic can alter the intestinal microbiota, so fluctuations in the international normalised ratio may occur during treatment with warfarin or other vitamin K antagonists. Coagulation parameters must therefore be monitored. Simultaneous use of several penicillin formulations can create hidden duplication: a patient may receive Bicillin-1 and then be prescribed another benzylpenicillin without recognising the shared active core. Substituting combination Bicillin C-R for Bicillin L-A in syphilis is particularly dangerous. The identical word Bicillin on the packaging does not indicate identical pharmacokinetics or therapeutic suitability.
Errors by Patients and Medical Personnel
The main patient error is to regard a long-acting antibiotic as a universal “powerful injection” for tonsillitis, a cold, sore throat, cough, or any inflammatory symptoms. Self-administration according to an old prescription, use of a leftover vial, repeating the course “to reinforce the effect,” and treatment without confirmation of a bacterial cause increase the risks of allergy and antimicrobial resistance without providing additional benefit in viral infection.
Increasing the dose or repeating the injection earlier than scheduled because rapid relief has not occurred is pointless and dangerous. The drug is already present in the tissue depot, while the symptoms may be caused by an incorrect diagnosis, a complication of the infection, or lack of susceptibility of the pathogen. The suspension must not be mixed with solutions intended for intravenous administration or injected through a vascular catheter. The injection should be given by a healthcare professional skilled in deep intramuscular administration and equipped to provide immediate treatment for anaphylaxis.
A dangerous medical error is prescribing the wrong dosage form. Benzathine, procaine, and water-soluble formulations of benzylpenicillin have different pharmacokinetics and are not automatically interchangeable. Benzathine benzylpenicillin is not intended for infections requiring rapid high antibiotic concentrations in the blood and is not an adequate treatment regimen for neurosyphilis. Use of the drug without establishing the stage of syphilis may result less in toxicity than in inadequate treatment of an ongoing infection.
Overdose, Accidental Administration, and Poisoning
No universal single toxic dose has been established for benzathine benzylpenicillin after which poisoning develops in every patient. Anaphylaxis is an immune reaction and may occur after a standard therapeutic dose. The severity of intravascular administration is also determined not by the total dose but by entry of the suspension into a blood vessel. Even an amount intended for standard intramuscular administration can cause immediate embolism, hypoxia, seizures, impaired consciousness, cardiorespiratory arrest, and death.
With excessive systemic exposure, penicillins may cause neuromuscular hyperexcitability, confusion, myoclonus, and seizures. The risk is higher in kidney failure, neurological disorders, at the extremes of age, and when several β-lactam antibiotics are prescribed simultaneously. There is no specific antidote. Treatment is supportive and includes stopping any further administration, monitoring respiration and circulation, controlling seizures, and correcting fluid and electrolyte disturbances. However, an intramuscular depot that has already been injected cannot be removed by standard methods, so observation must continue even after initial improvement.
In anaphylaxis, every minute matters. Waiting for the “full clinical picture” to develop increases the risk of irreversible hypoxia and circulatory arrest. Sudden excruciating pain during injection, rapid pallor or bluish discolouration of the skin, cooling of the limb, or impaired sensation or movement requires immediate assessment for vascular injury and Nicolau syndrome. Necrosis may progress over the following hours and days, so attempting to wait out the reaction at home risks loss of tissue, limb, and life.
Herbal Support for Mild Inflammation and Recovery After Antibiotic Treatment
In mild or moderate uncomplicated inflammation, when syphilis, streptococcal infection requiring antibiotic treatment, rheumatic fever, neuroinfection, and other conditions requiring reliable bactericidal therapy have been excluded, a combination of Plu Kao, Japanese honeysuckle (Lonicera japonica), and weeping forsythia (Forsythia suspensa) may be considered. This combination is intended to reduce the inflammatory response, support the mucous membranes, and help limit microbial burden. It may be used in a stable uncomplicated course, but it is not equivalent to benzathine benzylpenicillin in a confirmed infection requiring a systemic antibiotic.
Depending on the site and nature of the inflammation, the combination may be supplemented with Chinese goldthread (Coptis chinensis) or common barberry (Berberis vulgaris). Simultaneous inclusion of both berberine-containing plants is usually unnecessary because it increases the likelihood of pharmacological duplication and interactions. Purple echinacea and membranous milkvetch are more consistent with immunomodulatory and restorative support, lungwort with inflammation and irritation of the respiratory mucosa, while Cryptolepis buchananii requires stricter selection of indications and safety assessment.
The main integrative approach after benzathine benzylpenicillin is not an attempt to “neutralise” the intramuscular depot that has already been injected, but to restore the intestinal barrier, mucous membranes, microbiota, antioxidant defences, and tissue repair. Colostrum may be used as a basic component to support the mucosal barrier and local immune protection. A metal and xenobiotic detoxification complex should be regarded as support for the body’s physiological biotransformation and elimination systems after drug exposure, but not as an antidote or as emergency treatment for allergy, vascular injury, or overdose.
Additional anti-inflammatory and antioxidant support may be provided by turmeric, milk thistle, and Chinese foxglove. Milk thistle may be particularly appropriate in polypharmacy, concurrent hepatic stress, or altered biochemical parameters, but mandatory hepatoprotective treatment is not required for every patient after a single standard injection of benzathine benzylpenicillin. Orthosiphon may be used when there are separate urinary indications, although pronounced nephrotoxicity is not a typical central complication of benzathine benzylpenicillin.
Bracket fungus extract and Centella asiatica may be used for antioxidant and metabolic support. Centella is also consistent with the goals of supporting microcirculation and tissue repair, but it does not replace surgical and vascular care in cases of severe pain, pallor, bluish discolouration, cooling of the limb, or necrosis after injection. Lion’s mane mushroom may be included to support mucous membranes and gastrointestinal recovery. A universal regimen is not required for every patient. The composition of the recovery complex is determined by symptoms, duration of antibiotic treatment, concomitant medications, and examination results.
Actual Effectiveness of Benzathine Benzylpenicillin and Prescribing Errors
Benzathine benzylpenicillin is genuinely effective against infections caused by susceptible microorganisms when a prolonged low concentration of benzylpenicillin is required. The drug is used for primary, secondary, and certain forms of latent syphilis, selected streptococcal infections, and long-term prevention of recurrent rheumatic fever. In syphilis, parenteral penicillin remains the preferred treatment, but the specific formulation, dose, and duration depend on the stage and clinical manifestations of the disease.
The drug is not a universal antibiotic for every sore throat, fever, or “inflammation.” It has no effect on viruses, does not provide rapid high concentrations in severe systemic infection, and does not achieve sufficient levels in cerebrospinal fluid to treat neurosyphilis. In ocular, otic, or neurological involvement, use of the benzathine formulation alone may allow the infection to persist despite the appearance that treatment has been given.
Typical medical errors include prescribing without confirming the diagnosis, failing to assess the stage of syphilis, substituting a procaine or combination formulation for the benzathine form, violating weekly intervals, using the drug for a viral illness, and failing to perform subsequent serological monitoring. A particular error is assuming that an additional injection always improves the result. In early syphilis, additional doses of benzathine benzylpenicillin usually do not increase the effectiveness of the standard regimen, whereas in late latent disease an incomplete course may be insufficient.
Safety Monitoring During Treatment
Before administration, reactions to penicillins, cephalosporins, and other β-lactams must be clarified, including the nature of any previous reaction and any history of anaphylaxis. The injection must be given only by deep intramuscular administration by a healthcare professional in a setting where adrenaline, airway support equipment, and anti-shock treatment are available. The drug must not be administered intravenously, intra-arterially, subcutaneously, or near a major nerve or blood vessel.
After the injection, respiration, blood pressure, consciousness, skin condition, and the injection site must be monitored. Sudden shortness of breath, wheezing, generalised urticaria, swelling of the lips, tongue, or larynx, a drop in blood pressure, severe weakness, and loss of consciousness indicate anaphylaxis. This is not a situation for taking an antihistamine tablet and observing at home. Delay increases the risk of hypoxia and circulatory arrest.
Disproportionately severe burning pain during injection, rapid pallor or bluish discolouration of the skin, impaired sensation, limb weakness, loss of pulse, increasing swelling, or blister formation requires immediate assessment for vascular injury and Nicolau syndrome. Fever, abdominal pain, and watery or bloody diarrhoea during or after treatment may indicate antibiotic-associated colitis.
Laboratory monitoring is usually not required after a single standard administration. With repeated courses, long-term prophylaxis, kidney failure, polypharmacy, or the appearance of systemic symptoms, it is reasonable to monitor a complete blood count, creatinine, estimated glomerular filtration rate, ALT, AST, bilirubin, and clinical signs of superinfection. During treatment of syphilis, serological monitoring is required at intervals corresponding to the stage of the disease and current clinical guidelines. Disappearance of the rash or other symptoms alone does not confirm eradication of the infection.
How to Discontinue Treatment Correctly
Benzathine benzylpenicillin does not cause dependence or a withdrawal syndrome, so gradual dose reduction is not required. Once the injection has been administered, it is physically impossible to stop the drug’s action because the suspension remains in the intramuscular depot and continues to release benzylpenicillin. If an adverse reaction occurs, discontinuation means refusing further doses and treating the resulting complication, not stopping the action of the dose that has already been administered.
During a course consisting of several weekly injections, skipping an injection or extending the interval without medical advice may make the treatment inadequate. In late latent syphilis or syphilis of unknown duration, whether a delay is acceptable depends on the length of the interval and whether the patient is pregnant. In some cases, the entire course must be restarted. Strict adherence to the recommended intervals is particularly important during pregnancy.
The absence of a withdrawal syndrome must not be confused with the absence of consequences from stopping treatment. An incomplete course may lead to persistence of the infection, further damage to the nervous and cardiovascular systems, intrauterine infection of the fetus, or recurrence of rheumatic fever. Replacing long-acting penicillin with a herbal remedy after treatment has begun is appropriate only when the physician has reassessed the diagnosis and confirmed that no infection requiring completion of antibiotic therapy is present.
A Rational Approach to Treatment
Benzathine benzylpenicillin is justified when a susceptible bacterial pathogen has been confirmed and the prolonged action of the drug provides a clinical advantage. In syphilis, particularly during pregnancy, it may be not only the preferred treatment but the only recommended option capable of treating maternal infection while preventing congenital syphilis. It must not be replaced with herbal remedies merely to reduce the perceived “chemical burden.”
In mild uncomplicated inflammation without evidence of a bacterial infection, a herbal combination may be used instead of an unnecessary antibiotic. When an antibiotic is genuinely required, integrative therapies serve a different purpose: they support the mucous membranes, intestinal barrier, microbiota, antioxidant systems, and tissue recovery after treatment. This approach does not replace effective anti-infective therapy but helps reduce the consequences of polypharmacy and avoid the habit of prescribing a long-acting antibiotic for every inflammatory symptom.
If you have any questions about the subject of this article, you can ask a clinical pharmacologist in the comments or book a consultation using the following link:
0 comments